TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-48.76%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Total debt
Total debt on the balance sheet as of September 2023 : $8.2 M
According to TherapeuticsMD's latest financial reports the company's total debt is $8.2 M. A company’s total debt is the sum of all current and non-current debts.
TherapeuticsMD - Total debt on balance sheet (from 2005 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $8.75 M | -95.57% |
| 2021-12-31 | $0.19 B | -20.49% |
| 2020-12-31 | $0.24 B | 21.12% |
| 2019-12-31 | $0.20 B | 179.75% |
| 2018-12-31 | $73.38 M | |
| 2012-12-31 | $3.58 M | 52.73% |
| 2011-12-31 | $2.35 M | 211.87% |
| 2010-12-31 | $0.75 M | 25.59% |
| 2009-12-31 | $0.6 M | |
| 2005-12-31 | $0.08 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 863,442.17% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 723,754.22% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.51 M | -69.32% | 🇺🇸 USA |
 Royalty Pharma RPRX | $6.13 B | 74,684.13% | 🇬🇧 UK |
 Lannett Company LCI | $0.63 B | 7,696.54% | 🇺🇸 USA |